In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

China's largest drug distributor Sinopharm goes public

Executive Summary

Sinopharm Group, the largest drug distributor in China, has completed its initial public offering on the Hong Kong stock exchange. It grossed HKD8.73bn ($1.13bn) by selling 546mm shares for HKD16, the high end of its planned HKD12.25-16 price range.
Deal Industry
  • Distributors
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register